Skip to content
10-Q

Quarterly Report

Definitive Healthcare Corp. DH

0001193125-26-212063

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 4, 2026 105.52M sh
Shares Diluted Q1 2026 · Mar 31, 2026 104.68M sh
Shares Diluted Q1 2026 · Mar 31, 2025 112.78M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $0
Stock Repurchased Q1 2026 · Mar 31, 2025 $21.16M
Capex Q1 2026 · Mar 31, 2026 $3.2M
Capex Q1 2026 · Mar 31, 2025 $7.71M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $11.56M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $26.07M
Long Term Debt Q1 2026 · Mar 31, 2026 $153.99M
Long Term Debt Q1 2026 · Dec 31, 2025 $156.09M
Short Term Debt Q1 2026 · Mar 31, 2026 $8.75M
Short Term Debt Q1 2026 · Dec 31, 2025 $8.75M
Short Term Investments Q1 2026 · Mar 31, 2026 $20.45M
Short Term Investments Q1 2026 · Dec 31, 2025 $17.26M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $157.65M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $163.63M
Stockholders Equity Q1 2026 · Mar 31, 2026 $190.7M
Stockholders Equity Q1 2026 · Dec 31, 2025 $378.99M
Current Liabilities Q1 2026 · Mar 31, 2026 $140.4M
Current Liabilities Q1 2026 · Dec 31, 2025 $156.79M
Total Liabilities Q1 2026 · Mar 31, 2026 $324.04M
Total Liabilities Q1 2026 · Dec 31, 2025 $356.5M
Current Assets Q1 2026 · Mar 31, 2026 $245.76M
Current Assets Q1 2026 · Dec 31, 2025 $257.61M
Total Assets Q1 2026 · Mar 31, 2026 $514.74M
Total Assets Q1 2026 · Dec 31, 2025 $735.49M
Eps Diluted Q1 2026 · Mar 31, 2026 −$1.32
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.95
Eps Basic Q1 2026 · Mar 31, 2026 −$1.32
Eps Basic Q1 2026 · Mar 31, 2025 −$0.95
Sga Expense Q1 2026 · Mar 31, 2026 $12.08M
Sga Expense Q1 2026 · Mar 31, 2025 $12.27M
Rd Expense Q1 2026 · Mar 31, 2026 $6.5M
Rd Expense Q1 2026 · Mar 31, 2025 $9.3M
Net Income Q1 2026 · Mar 31, 2026 −$138.62M
Net Income Q1 2026 · Mar 31, 2025 −$107.23M
Operating Income Q1 2026 · Mar 31, 2026 −$201.29M
Operating Income Q1 2026 · Mar 31, 2025 −$184.79M
Gross Profit Q1 2026 · Mar 31, 2026 $41.65M
Gross Profit Q1 2026 · Mar 31, 2025 $43.76M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $14.28M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $15.43M
Revenue Q1 2026 · Mar 31, 2026 $55.93M
Revenue Q1 2026 · Mar 31, 2025 $59.19M